GPC2 provides prognostic value in pan-pediatric cancers and is associated with MYCN amplification in neuroblastoma: bioinformatics analysis and validation.

BMC Cancer · 2026 · PMC13107834 · PMID 41840507

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Except osteosarcoma, high GPC2 expression showed a trend of lower survival rate in the remaining six pediatric tumors, particularly in cases of NB and brain tumors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.